Limited Coverage Drugs - Special Authority Criteria

Generic Name / Strength / Form
dalteparin

Criteria Approval Period
1. Treatment of acute deep vein thrombosis or pulmonary emboli.1. Up to ten days supply

OR

2. Failure on oral anticoagulant treatment (reoccurrence of one or more deep vein thrombosis or pulmonary emboli) or failure to reach therapeutic INR while on oral anticoagulants. 2. Up to three months

OR

3. Prophylaxis of lupus anticoagulant syndrome, antiphospholipid syndrome or thrombophilia. 3. Up to three months

OR

4. Prophylaxis post-operative after total knee arthroplasty or major orthopedic trauma. 4. Up to ten days

OR

5. Pregnancy. 5. Up to four weeks post-partum.

Practitioner Exemptions

  • No practitioner exemptions

Special Notes

  • None

Low Molecular Weight Heparin Form (PDF)
Click on the link to complete the special authority request form.